WallStSmart
CLGN

Collplant Biotechnologies Ltd

NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY

$0.37
-4.51% today

Updated 2026-04-29

Market cap
$6.00M
P/E ratio
P/S ratio
2.53x
EPS (TTM)
$-0.94
Dividend yield
52W range
$0 – $5
Volume
0.1M

Collplant Biotechnologies Ltd (CLGN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-57.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-12.2%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-17.4%
2026-04-02
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-02$0.00+100.0%$0.53$0.44-17.4%
2026-03-26$-0.25-31.6%$0.75$0.62-16.9%
2025-11-26$-0.25-256.3%$2.24$2.19-2.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.13$0.00+100.0%
2025-12-31$-0.19$-0.25-31.6%$60000.00-63.4%
2025-09-30$0.16$-0.25-256.3%$77000.00+1825.0%
2025-06-30$-0.14$-0.28-100.0%$179000.00-28.1%
2025-03-31$-0.04$-0.13-225.0%$2.06M+1996.9%
2024-12-31$-0.28$-0.33-20.0%$164000.00-45.2%
2024-09-30$-0.28$-0.38-35.7%$4000.00-90.7%
2024-06-30$-0.27$-0.37-37.0%$249000.00
2024-03-31$-0.35$-0.37-5.7%$98000.00
2023-12-31$-0.07$-0.24-242.9%$299000.00
2023-09-30$-0.13$-0.38-192.3%$43000.00

Frequently asked questions

Has Collplant Biotechnologies Ltd beaten earnings estimates?
Collplant Biotechnologies Ltd has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -57.9% over the last 4 quarters.
How does CLGN stock react to earnings?
CLGN stock has moved an average of -12.2% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.